Newron Pharmaceuticals
NWRN.SW
#8592
Rank
NZ$0.24 B
Marketcap
$12.76
Share price
-5.96%
Change (1 day)
-14.84%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -NZ$32 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are NZ$10.01 Million. In 2023 the company made an earning of -NZ$32 Million, an increase over its 2022 earnings that were of -NZ$33.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-NZ$32 Million-4.45%
2022-NZ$33.49 Million11.19%
2021-NZ$30.12 Million-30.14%
2020-NZ$43.12 Million6.84%
2019-NZ$40.36 Million31.45%
2018-NZ$30.7 Million170.13%
2017-NZ$11.37 Million-60.23%
2016-NZ$28.58 Million-41.46%
2015-NZ$48.81 Million109.46%
2014-NZ$23.31 Million22.43%
2013-NZ$19.04 Million222.49%
2012-NZ$5.91 Million-60.49%
2011-NZ$14.94 Million-71%
2010-NZ$51.51 Million-17.37%
2009-NZ$62.34 Million52.58%
2008-NZ$40.86 Million41.24%
2007-NZ$28.93 Million-25.19%
2006-NZ$38.67 Million22.45%
2005-NZ$31.58 Million